Moojen 2013.
Methods | Multi‐centre double blinded RCT Setting: 5 neurosurgical centres in the Netherlands Country: Netherlands Period: October 2008 to September 2011 |
|
Participants |
Number: 159 patients (79/80) Diagnosis: clinical diagnosis of neurogenic claudication by a neurologist with MRI findings of spinal canal stenosis Included: patients between 40 and 85 years; 3 months of neurogenic claudication; single or 2‐level degenerative lumbar canal stenosis; indication for surgery Excluded: cauda equina syndrome; herniated disc needing discectomy; history of surgery; significant scoliosis Age (years): mean 64/66 BMI (kg/m²): mean (range) 28 (20‐37)/27 (20‐48) Lumbar stenosis duration (years): mean (range) 1.9 (0.1‐17) |
|
Interventions |
Group 1: decompression (laminotomy, flavectomy, facetectomy). In the decompression group, a partial resection of the adjacent laminas was executed, followed by a flavectomy with bilateral opening of the lateral recess and, if necessary, a medial facetectomy was done Group 2: interspinous process spacer device (Paradigm Spine, USA). In the experimental group, no bony decompression was done and the interspinous process device was implanted by a posterior midline approach. Follow‐up: 12 months |
|
Outcomes |
Pain: 100 mm VAS leg pain Disability: RMDQ Function: ZCQ (physical function) Costs Operation time Perioperative blood loss Complications Reoperations Length of hospital stay |
|
Notes |
Surgeon's experience: not reported Funding: "Paradigm Spine funded this trial. Paradigm Spine had no role in data collection, design of the study, data analysis, interpretation of data, or writing the report and had no influence over whether to submit the manuscript. All the researchers were individually independent from funders" |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "randomized design with variable block sizes, with allocations stratified according to center." |
Allocation concealment (selection bias) | Low risk | Quote: "opaque, coded and sealed envelopes". "After induction of anaesthesia, the prepared envelope was opened and the patient allocated to one of the treatment arms." |
Blinding of participants (performance bias) All outcomes | Low risk | Quote: "patients, nurses on the hospital wards, and research nurses remained blind to the allocated treatment during the follow‐up period of one year." |
Bliding of personnel/ care providers (performance bias) | High risk | The surgeon could not have been blinded to the intervention. |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Quote: "all caregivers blind to the allocated treatment." |
Incomplete outcome data (attrition bias) All outcomes | Low risk | 151/159 = 95% of the patients completed the follow‐up. The number of drop‐outs is unlikely to affect the results. |
Intention‐to‐treat analysis (attrition bias) | Low risk | Quote: "we compared groups on the basis of an intention to treat analysis." |
Selective reporting (reporting bias) | Low risk | All expected outcomes were reported. |
Group similarity at baseline (selection bias) | Low risk | Patients did not differ in their baseline characteristics, based on Table 1. |
Co‐interventions (performance bias) | Low risk | Only the surgical technique differed between treatment groups. All participants received the same postoperative care. |
Compliance (performance bias) | Low risk | Compliance in both treatment groups: 100% (surgery). |
Timing of outcome assessment (detection bias) | Low risk | All important outcome assessments for both groups were measured at the same time. |
Other bias | Low risk | Quote: "Paradigm Spine funded this trial. Paradigm Spine had no role in data collection, design of the study, data analysis, interpretation of data, or writing the report and had no influence over whether to submit the manuscript. All the researchers were individually independent from funders." |